New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - abacavir sulfate 702mg equivalent to abacavir 600 mg;  ; dolutegravir sodium 52.6mg equivalent to dolutegravir 50 mg;  ;  ;  ; lamivudine 300mg;   - film coated tablet - 50mg/600mg/300mg - active: abacavir sulfate 702mg equivalent to abacavir 600 mg   dolutegravir sodium 52.6mg equivalent to dolutegravir 50 mg       lamivudine 300mg   excipient: magnesium stearate mannitol microcrystalline cellulose opadry purple 85f90057 povidone sodium starch glycolate - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age who are antiretroviral treatment-na?ve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents (dolutegravir, abacavir or lamivudine) in triumeq.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - abacavir - film-coated tablet - 300 milligram(s) - abacavir

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - abacavir - film-coated tablet - abacavir 300 mg - antivirals for systemic use

Malta - English - Medicines Authority

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - abacavir, lamivudine - film-coated tablet - abacavir 600 mg lamivudine 300 mg - antivirals for systemic use

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - abacavir, lamivudine - film-coated tablet - abacavir 600 mg lamivudine 300 mg - antivirals for systemic use

Canada - English - Health Canada

mylan pharmaceuticals ulc - abacavir (abacavir sulfate); lamivudine - tablet - 600mg; 300mg - abacavir (abacavir sulfate) 600mg; lamivudine 300mg - nucleoside and nucleotide reverse transcriptase inhibitors

Namibia - English - Namibia Medicines Regulatory Council

cipla medpro (pty) ltd - abacavir sulphate - tablet - each film-coated tablet contains abacavir sulphate equivalent to abacavir 300 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - abacavir sulfate,lamivudine -

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - abacavir sulfate 702mg equivalent to abacavir 600 mg;  ;  ; lamivudine 300mg;   - film coated tablet - 600mg/300mg - active: abacavir sulfate 702mg equivalent to abacavir 600 mg     lamivudine 300mg   excipient: magnesium stearate microcrystalline cellulose opadry orange ys-1-13065a sodium starch glycolate - kivexa is a combination of two nucleoside analogues (abacavir and lamivudine). it is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - abacavir sulfate 351mg equivalent to 300 mg abacavir;  ;   - film coated tablet - 300 mg - active: abacavir sulfate 351mg equivalent to 300 mg abacavir     excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry yellow ys-1-12789-a purified water sodium starch glycolate - ziagen is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and children.